Voloridge Investment Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-51,629	Closed	-$1.54M	–	1219
2023 Q3	$1.54M	Buy	+51,629	New	+$1.54M	0.01%	994